Decibel Bio is a Berkeley, CA-based company that provides an epigenetic reprogramming platform for crops. Led by CEO and founder Travis Bayer, the company develops treatments that boost genes protecting plants' photosynthetic machinery from extreme heat, helping them remain productive under stress. The same approach is described as working for drought, excess rainfall, and for yield enhancement. Decibel aims to advance its proprietary platform for both reading and writing the plant epigenome to create crop varieties with higher yield, efficiency, and resilience. The company raised $12M in funding from Breakthrough Energy Ventures, Future Ventures, Bayer and Syngenta. It intends to use the funds to expand partnerships across the platform and fast track product development.

Total raised

$12M

Funding rounds

1

Latest round

Equity

Latest activity

Mar 2025